Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hypertension 2 Breast Neoplasms 2 Small Cell Lung Carcinoma 1 Sarcoma 1 Radiation Injuries 1 Prostatic Neoplasms 1 Non-alcoholic Fatty Liver Disease 1 Lymphoma, Follicular 1 Lymphoma 1 Hematologic Neoplasms 1 Dyspnea 1 Cardiotoxicity 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Breast Neoplasms, Male 1

Interventions

Cyclophosphamide 176 Rituximab 164 fludarabine phosphate 97 Peripheral Blood Stem Cell Transplantation 95 Filgrastim 73 Etoposide 67 Radiotherapy 63 Mycophenolic Acid 62 Whole-Body Irradiation 58 Tacrolimus 49 Melphalan 49 Cyclosporine 49 Busulfan 47 Lenalidomide 45 Antilymphocyte Serum 39 Vincristine 37 Prednisone 37 Cytarabine 37 fludarabine 35 Methotrexate 33 Carmustine 32 obinutuzumab 31 Doxorubicin 30 Bendamustine Hydrochloride 30 Methylprednisolone 27 ibritumomab tiuxetan 25 Cord Blood Stem Cell Transplantation 25 sargramostim 24 Bortezomib 24 Granulocyte Colony-Stimulating Factor 22

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Lymphoma, Follicular × Lisinopril × Clear all

NCT01258764 2015-05-20

1HAT

Scripps Translational Science Institute

Phase NA Completed

Hypertension, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡